AbbVie to Host First-Quarter 2023 Earnings Conference Call
AbbVie (NYSE: ABBV) is set to announce its first-quarter 2023 financial results on April 27, 2023, before the market opens.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
AbbVie (NYSE: ABBV) is set to announce its first-quarter 2023 financial results on April 27, 2023, before the market opens. A live webcast of the earnings conference call will take place at 8 a.m. CT and will be accessible via AbbVie’s Investor Relations website. This follows the company's mission to deliver innovative medicines addressing major health issues across various therapeutic areas, including immunology, oncology, and more. For more details, investors can visit investors.abbvie.com.
Positive
- Upcoming earnings call on April 27, 2023, could provide insights into future growth.
- Broad therapeutic focus including immunology and oncology may attract investor interest.
Negative
- None.
Details
News Market Reaction – ABBV
The recorded move for ABBV in the trading session of this news was -0.40%.
Data tracked by StockTitan Argus. Session date unavailable.
AI-generated analysis. How Rhea-AI works. Not financial advice.
NORTH CHICAGO, Ill., April 4, 2023 /PRNewswire/ -- AbbVie (NYSE: ABBV) will announce its first-quarter 2023 financial results on Thursday, April 27, 2023, before the market opens. AbbVie will host a live webcast of the earnings conference call at 8 a.m. CT. It will be accessible through AbbVie's Investor Relations website investors.abbvie.com. An archived edition of the session will be available later that day.
About AbbVie
AbbVie's mission is to discover and deliver innovative medicines that solve serious health issues today and address the medical challenges of tomorrow. We strive to have a remarkable impact on people's lives across several key therapeutic areas: immunology, oncology, neuroscience, eye care, virology and gastroenterology, in addition to products and services across its Allergan Aesthetics portfolio. For more information about AbbVie, please visit us at www.abbvie.com. Follow @abbvie on Twitter, Facebook, Instagram, YouTube and LinkedIn.
View original content:https://www.prnewswire.com/news-releases/abbvie-to-host-first-quarter-2023-earnings-conference-call-301788964.html
SOURCE AbbVie
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.